ArticleCancer research2025

Concurrent Inhibition of the RAS-MAPK Pathway and PIKfyve Is a Therapeutic Strategy for Pancreatic Cancer.

Jonathan M DeLiberty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.